Header Logo

Neilayan Sen

Concepts (71)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Radiation Oncology
3
2019
14
0.460
Why?
Pancreatic Neoplasms
1
2014
97
0.420
Why?
Employment
2
2018
45
0.290
Why?
Chemoradiotherapy
2
2019
61
0.270
Why?
Sarcoma
2
2019
144
0.240
Why?
Internship and Residency
2
2019
219
0.240
Why?
Carcinoma, Non-Small-Cell Lung
2
2017
244
0.220
Why?
Lung Neoplasms
2
2017
553
0.180
Why?
Human papillomavirus 16
1
2019
6
0.160
Why?
Oropharyngeal Neoplasms
1
2019
20
0.160
Why?
Biopsy, Fine-Needle
1
2019
61
0.160
Why?
Career Choice
1
2018
30
0.150
Why?
Tongue Neoplasms
1
2018
19
0.150
Why?
Neoadjuvant Therapy
2
2019
66
0.150
Why?
Carcinoma, Squamous Cell
1
2019
177
0.140
Why?
Antineoplastic Combined Chemotherapy Protocols
1
2019
241
0.140
Why?
Radiosurgery
1
2017
38
0.140
Why?
Brachytherapy
1
2016
56
0.130
Why?
Prognosis
2
2019
825
0.130
Why?
Radiotherapy, Adjuvant
1
2014
52
0.110
Why?
United States
4
2019
2197
0.100
Why?
Humans
10
2019
28408
0.100
Why?
Retrospective Studies
4
2019
3609
0.080
Why?
Treatment Outcome
4
2019
3615
0.080
Why?
Chi-Square Distribution
2
2018
146
0.070
Why?
Male
6
2019
15273
0.070
Why?
Female
6
2019
15708
0.070
Why?
Disease-Free Survival
2
2018
177
0.070
Why?
Databases, Factual
2
2019
358
0.070
Why?
Neoplasm Staging
2
2018
371
0.060
Why?
Adult
4
2019
8097
0.060
Why?
Cohort Studies
2
2019
1926
0.050
Why?
Aged
3
2019
9262
0.040
Why?
Genetic Heterogeneity
1
2019
9
0.040
Why?
Mesna
1
2019
3
0.040
Why?
Population Density
1
2018
7
0.040
Why?
Ifosfamide
1
2019
13
0.040
Why?
Job Application
1
2018
8
0.040
Why?
Cities
1
2018
17
0.040
Why?
Clinical Decision-Making
1
2019
44
0.040
Why?
Organ Sparing Treatments
1
2019
11
0.040
Why?
Reference Values
1
2019
194
0.040
Why?
Consumer Behavior
1
2018
23
0.040
Why?
Cyclin-Dependent Kinase Inhibitor p16
1
2018
25
0.040
Why?
Schools, Medical
1
2018
27
0.040
Why?
Leg
1
2019
52
0.040
Why?
Doxorubicin
1
2019
54
0.040
Why?
Arm
1
2019
84
0.040
Why?
Neoplasm Invasiveness
1
2018
89
0.040
Why?
Combined Modality Therapy
1
2019
307
0.040
Why?
Analysis of Variance
1
2018
269
0.040
Why?
Professional Practice Location
1
2017
2
0.040
Why?
Survival Rate
1
2018
356
0.040
Why?
Academies and Institutes
1
2017
10
0.040
Why?
Censuses
1
2017
9
0.040
Why?
Radiotherapy Dosage
1
2017
117
0.030
Why?
Kaplan-Meier Estimate
1
2017
179
0.030
Why?
Patient Safety
1
2017
54
0.030
Why?
Risk Assessment
1
2019
676
0.030
Why?
Registries
1
2017
188
0.030
Why?
Societies, Medical
1
2017
154
0.030
Why?
Age Factors
1
2018
781
0.030
Why?
Chemoradiotherapy, Adjuvant
1
2015
17
0.030
Why?
Middle Aged
2
2019
9254
0.030
Why?
Survival Analysis
1
2015
267
0.030
Why?
Surveys and Questionnaires
1
2018
1216
0.030
Why?
Adolescent
1
2018
2307
0.020
Why?
Young Adult
1
2018
2069
0.020
Why?
Prospective Studies
1
2017
1805
0.020
Why?
Follow-Up Studies
1
2017
1858
0.020
Why?
Aged, 80 and over
1
2017
4853
0.020
Why?
Sen's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (71)
Explore
_
Co-Authors (19)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_